Translational Research in Oncology
A mid-level position within Edison’s Data & Settlement Services team providing analytical support to natural gas and electricity energy managers in Edison’s Energy Supply Advisory service line.
Translational Research in Oncology (TRIO) is an academic clinical research organization focused on advancing cancer treatment through international oncology trials and translational research. It collaborates with investigators, academic institutions, and industry partners to design and conduct clinical studies aimed at improving outcomes for cancer patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Translational Research in Oncology.
Translational Research in Oncology didn’t post a salary, so this is our estimate from similar listings.